NAT2 and NER genetic variants and sporadic prostate cancer susceptibility in African Americans

[1]  S. Stewart,et al.  Family History, Perceived Risk, and Prostate Cancer Screening among African American Men , 2006, Cancer Epidemiology Biomarkers & Prevention.

[2]  C. Engel,et al.  N-Acetyltransferase (NAT) 2 acetylator status and age of tumour onset in patients with sporadic and familial, microsatellite stable (MSS) colorectal cancer , 2006, International Journal of Colorectal Disease.

[3]  Leah E. Mechanic,et al.  Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. , 2006, Carcinogenesis.

[4]  H. Glatt,et al.  N-Acetyltransferase and sulfotransferase activity in human prostate: potential for carcinogen activation , 2006, Pharmacogenetics and genomics.

[5]  F. Clavel-Chapelon,et al.  No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. , 2006, Cancer Epidemiology, Biomarkers and Prevention.

[6]  N. Malats,et al.  Genetic Variation in the Nucleotide Excision Repair Pathway and Bladder Cancer Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[7]  Nilanjan Chatterjee,et al.  Nucleotide Excision Repair Gene Polymorphisms and Risk of Advanced Colorectal Adenoma: XPC Polymorphisms Modify Smoking-Related Risk , 2006, Cancer Epidemiology Biomarkers & Prevention.

[8]  A. Zlotta.  NAT2 Slow Acetylation, GSTM1 Null Genotype, and Risk of Bladder Cancer: Results from the Spanish Bladder Cancer Study and Meta-Analyses , 2006 .

[9]  F. Collins,et al.  A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history , 2005, Journal of Medical Genetics.

[10]  R. D. Mittal,et al.  Genetic polymorphism of the N-acetyltransferase 2 gene, and susceptibility to prostate cancer: a pilot study in north Indian population. , 2005 .

[11]  D. Pinto,et al.  Acetylation genotype and the genetic susceptibility to prostate cancer in a southern European population , 2005, The Prostate.

[12]  A. Chokkalingam,et al.  Genetic Variants of DNA Repair Genes and Prostate Cancer: A Population-Based Study , 2005, Cancer Epidemiology Biomarkers & Prevention.

[13]  W. Tassaneeyakul,et al.  Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma , 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[14]  Jennifer J. Hu,et al.  Nucleotide-excision repair and prostate cancer risk. , 2005, Cancer letters.

[15]  Dong Liang,et al.  Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. , 2005, Mutation research.

[16]  M. Shriver,et al.  Ancestral proportions and their association with skin pigmentation and bone mineral density in Puerto Rican women from New York city , 2004, Human Genetics.

[17]  H. Glatt,et al.  Risk of Colorectal Adenomas in Relation to Meat Consumption, Meat Preparation, and Genetic Susceptibility in a Dutch Population , 2004, Cancer Causes & Control.

[18]  K. Lohman,et al.  Deficient Nucleotide Excision Repair Capacity Enhances Human Prostate Cancer Risk , 2004, Cancer Research.

[19]  J. Witte,et al.  DNA Repair Gene XRCC1 and XPD Polymorphisms and Risk of Prostate Cancer , 2004, Cancer Epidemiology Biomarkers & Prevention.

[20]  M. Stephens,et al.  Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. , 2003, Genetics.

[21]  Mark D Shriver,et al.  Control of confounding of genetic associations in stratified populations. , 2003, American journal of human genetics.

[22]  T. Katoh,et al.  N‐acetyltransferase‐2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men , 2003, International journal of urology : official journal of the Japanese Urological Association.

[23]  Li Jin,et al.  Skin pigmentation, biogeographical ancestry and admixture mapping , 2003, Human Genetics.

[24]  Peter H. Westfall,et al.  Testing Association of Statistically Inferred Haplotypes with Discrete and Continuous Traits in Samples of Unrelated Individuals , 2002, Human Heredity.

[25]  M. Spitz,et al.  Reduced expression levels of nucleotide excision repair genes in lung cancer: a case-control analysis. , 2000, Carcinogenesis.

[26]  D. Hein.  N-Acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis. , 2000, Toxicology letters.

[27]  H. Tohgi,et al.  The methylation status of cytosines in a τ gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex , 1999, Neuroscience Letters.

[28]  H. Frierson,et al.  Loss of heterozygosity and lack of mutations of the XPG/ERCC5 DNA repair gene at 13q33 in prostate cancer , 1999, The Prostate.

[29]  D. Alberts,et al.  Expression in normal human tissues of five nucleotide excision repair genes measured simultaneously by multiplex reverse transcription-polymerase chain reaction. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  G. Haas,et al.  N-Acetyltransferase expression and DNA binding of N-hydroxyheterocyclic amines in human prostate epithelium. , 1999, Carcinogenesis.

[31]  G. Haas,et al.  Heterocyclic amines and genotype of N-acetyltransferases as risk factors for prostate cancer , 2005, Prostate Cancer and Prostatic Diseases.

[32]  S. Devesa,et al.  International trends and patterns of prostate cancer incidence and mortality , 2000, International journal of cancer.

[33]  T. Lindahl,et al.  Base excision repair of oxidative DNA damage activated by XPG protein. , 1999, Molecular cell.